Phibro Animal Health Corp (PAHC): Revenue
$1.52B
Year ended 2026-06-30
+15.8%
3-year compound annual growth
+12.7%
5-year compound annual growth
+7.3%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $1.52B | +17.1% | 2026-08-26, From 2025-07-01 |
| 2025-06-30 | $1.30B | +27.4% | 2026-08-26, From 2024-07-01 |
| 2024-06-30 | $1.02B | +4.1% | 2026-08-26, From 2023-07-01 |
| 2023-06-30 | $977.89M | +3.8% | 2025-08-27, From 2022-07-01 |
| 2022-06-30 | $942.26M | +13.1% | 2024-08-28, From 2021-07-01 |
| 2021-06-30 | $833.35M | +4.1% | 2023-08-30, From 2020-07-01 |
| 2020-06-30 | $800.35M | -3.3% | 2022-08-24, From 2019-07-01 |
| 2019-06-30 | $828.00M | +1.0% | 2021-08-25, From 2018-07-01 |
| 2018-06-30 | $819.98M | +7.3% | 2020-08-26, From 2017-07-01 |
| 2017-06-30 | $764.28M | +1.7% | 2018-08-27, From 2016-07-01 |
| 2016-06-30 | $751.53M | +0.4% | 2018-08-27, From 2015-07-01 |
| 2015-06-30 | $748.59M | +8.2% | 2017-08-30, From 2014-07-01 |
| 2014-06-30 | $691.91M | +5.9% | 2016-08-29, From 2013-07-01 |
| 2013-06-30 | $653.15M | -0.1% | 2015-09-10, From 2012-07-01 |
| 2012-06-30 | $654.10M | n/a | 2014-09-18, From 2011-07-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $1.52B | +17.1% |
| Alkermes plc. (ALKS) | 2025-12-31 | $1.48B | -5.2% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $1.73B | +114.5% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.24B | +4.3% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.09B | -4.3% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.07B | +11.9% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $2.20B | +15.6% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $2.38B | +5.1% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $958.40M | +432.1% |
Compare PAHC, ALKS, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗